Veea (VEEA) Competitors

$0.60 +0.00 (+0.59%)

Closing price 05/19/2026 04:00 PM Eastern

Extended Trading

$0.58 -0.02 (-3.80%)

As of 05/19/2026 07:07 PM Eastern

VEEA vs. PODC, CANG, HCAT, DH, and EXFY

Should you buy Veea stock or one of its competitors? MarketBeat compares Veea with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Veea include PodcastOne (PODC), Cango (CANG), Health Catalyst (HCAT), Definitive Healthcare (DH), and Expensify (EXFY). These companies are all part of the "computer software" industry.

How does Veea compare to PodcastOne?

Veea (NASDAQ:VEEA) and PodcastOne (NASDAQ:PODC) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

PodcastOne has a net margin of -6.22% compared to Veea's net margin of -804.53%. Veea's return on equity of 0.00% beat PodcastOne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veea	-804.53%	N/A	-46.79%
PodcastOne	-6.22%	-24.78%	-16.46%

Veea has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market. Comparatively, PodcastOne has a beta of 1.72, suggesting that its stock price is 72% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veea	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
PodcastOne	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

25.9% of Veea shares are owned by institutional investors. Comparatively, 2.9% of PodcastOne shares are owned by institutional investors. 60.8% of Veea shares are owned by insiders. Comparatively, 79.4% of PodcastOne shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

PodcastOne has higher revenue and earnings than Veea. PodcastOne is trading at a lower price-to-earnings ratio than Veea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veea	$220K	136.75	-$6.66M	-$0.37	N/A
PodcastOne	$52.12M	2.06	-$6.46M	-$0.15	N/A

In the previous week, PodcastOne had 8 more articles in the media than Veea. MarketBeat recorded 9 mentions for PodcastOne and 1 mentions for Veea. Veea's average media sentiment score of 1.38 beat PodcastOne's score of -0.24 indicating that Veea is being referred to more favorably in the media.

Company	Overall Sentiment
Veea	Positive
PodcastOne	Neutral

Summary

PodcastOne beats Veea on 9 of the 14 factors compared between the two stocks.

How does Veea compare to Cango?

Cango (NYSE:CANG) and Veea (NASDAQ:VEEA) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Veea has lower revenue, but higher earnings than Cango. Veea is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cango	$688.08M	0.12	-$621.95M	-$2.97	N/A
Veea	$220K	136.75	-$6.66M	-$0.37	N/A

In the previous week, Cango had 12 more articles in the media than Veea. MarketBeat recorded 13 mentions for Cango and 1 mentions for Veea. Veea's average media sentiment score of 1.38 beat Cango's score of -0.28 indicating that Veea is being referred to more favorably in the news media.

Company	Overall Sentiment
Cango	Neutral
Veea	Positive

4.2% of Cango shares are owned by institutional investors. Comparatively, 25.9% of Veea shares are owned by institutional investors. 29.1% of Cango shares are owned by insiders. Comparatively, 60.8% of Veea shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cango has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, Veea has a beta of 0.16, meaning that its share price is 84% less volatile than the broader market.

Cango presently has a consensus price target of $3.00, suggesting a potential upside of 526.30%. Given Cango's stronger consensus rating and higher possible upside, equities analysts plainly believe Cango is more favorable than Veea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cango	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Veea	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cango has a net margin of -83.92% compared to Veea's net margin of -804.53%. Veea's return on equity of 0.00% beat Cango's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cango	-83.92%	-49.13%	-24.42%
Veea	-804.53%	N/A	-46.79%

Summary

Cango beats Veea on 10 of the 17 factors compared between the two stocks.

How does Veea compare to Health Catalyst?

Veea (NASDAQ:VEEA) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

In the previous week, Health Catalyst had 6 more articles in the media than Veea. MarketBeat recorded 7 mentions for Health Catalyst and 1 mentions for Veea. Veea's average media sentiment score of 1.38 beat Health Catalyst's score of -0.11 indicating that Veea is being referred to more favorably in the media.

Company	Overall Sentiment
Veea	Positive
Health Catalyst	Neutral

Veea has higher earnings, but lower revenue than Health Catalyst. Veea is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veea	$220K	136.75	-$6.66M	-$0.37	N/A
Health Catalyst	$311.14M	0.30	-$177.97M	-$3.72	N/A

25.9% of Veea shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 60.8% of Veea shares are owned by company insiders. Comparatively, 2.6% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Health Catalyst has a net margin of -87.69% compared to Veea's net margin of -804.53%. Veea's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veea	-804.53%	N/A	-46.79%
Health Catalyst	-87.69%	-3.52%	-1.77%

Veea has a beta of 0.16, suggesting that its share price is 84% less volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market.

Health Catalyst has a consensus target price of $2.77, indicating a potential upside of 118.32%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts plainly believe Health Catalyst is more favorable than Veea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veea	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23

Summary

Health Catalyst beats Veea on 10 of the 16 factors compared between the two stocks.

How does Veea compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and Veea (NASDAQ:VEEA) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 25.9% of Veea shares are held by institutional investors. 14.8% of Definitive Healthcare shares are held by company insiders. Comparatively, 60.8% of Veea shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Definitive Healthcare had 2 more articles in the media than Veea. MarketBeat recorded 3 mentions for Definitive Healthcare and 1 mentions for Veea. Veea's average media sentiment score of 1.38 beat Definitive Healthcare's score of 0.43 indicating that Veea is being referred to more favorably in the news media.

Company	Overall Sentiment
Definitive Healthcare	Neutral
Veea	Positive

Veea has lower revenue, but higher earnings than Definitive Healthcare. Veea is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.38	-$138.93M	-$1.62	N/A
Veea	$220K	136.75	-$6.66M	-$0.37	N/A

Definitive Healthcare currently has a consensus price target of $2.77, indicating a potential upside of 217.61%. Given Definitive Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Definitive Healthcare is more favorable than Veea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.00
Veea	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Definitive Healthcare has a net margin of -76.04% compared to Veea's net margin of -804.53%. Definitive Healthcare's return on equity of 4.04% beat Veea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-76.04%	4.04%	1.99%
Veea	-804.53%	N/A	-46.79%

Definitive Healthcare has a beta of 1.34, indicating that its stock price is 34% more volatile than the broader market. Comparatively, Veea has a beta of 0.16, indicating that its stock price is 84% less volatile than the broader market.

Summary

Definitive Healthcare beats Veea on 12 of the 17 factors compared between the two stocks.

How does Veea compare to Expensify?

Veea (NASDAQ:VEEA) and Expensify (NASDAQ:EXFY) are both small-cap computer software companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Expensify has a net margin of -14.68% compared to Veea's net margin of -804.53%. Veea's return on equity of 0.00% beat Expensify's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veea	-804.53%	N/A	-46.79%
Expensify	-14.68%	-15.26%	-10.96%

Expensify has a consensus target price of $2.50, indicating a potential upside of 121.24%. Given Expensify's stronger consensus rating and higher probable upside, analysts clearly believe Expensify is more favorable than Veea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veea	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Expensify	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

25.9% of Veea shares are held by institutional investors. Comparatively, 68.4% of Expensify shares are held by institutional investors. 60.8% of Veea shares are held by company insiders. Comparatively, 11.7% of Expensify shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Veea has a beta of 0.16, indicating that its share price is 84% less volatile than the broader market. Comparatively, Expensify has a beta of 1.75, indicating that its share price is 75% more volatile than the broader market.

In the previous week, Expensify had 4 more articles in the media than Veea. MarketBeat recorded 5 mentions for Expensify and 1 mentions for Veea. Veea's average media sentiment score of 1.38 beat Expensify's score of 0.77 indicating that Veea is being referred to more favorably in the media.

Company	Overall Sentiment
Veea	Positive
Expensify	Positive

Veea has higher earnings, but lower revenue than Expensify. Expensify is trading at a lower price-to-earnings ratio than Veea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veea	$220K	136.75	-$6.66M	-$0.37	N/A
Expensify	$142.10M	0.67	-$21.39M	-$0.23	N/A

Summary

Expensify beats Veea on 9 of the 15 factors compared between the two stocks.

Get Veea News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VEEA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VEEA vs. The Competition

Export

Metric	Veea	INTERNET SOFTWARE Industry	Computer Sector	NASDAQ Exchange
Market Cap	$29.91M	$16.54B	$38.65B	$12.23B
Dividend Yield	N/A	4.90%	3.21%	5.32%
P/E Ratio	-1.62	62.77	167.09	25.05
Price / Sales	136.75	36.98	627.38	72.69
Price / Cash	N/A	67.68	46.83	54.25
Price / Book	6.00	8.95	10.09	6.83
Net Income	-$6.66M	$379.18M	$1.06B	$335.69M
7 Day Performance	15.12%	1.32%	-0.84%	-2.15%
1 Month Performance	-7.01%	-1.76%	2.72%	-2.47%
1 Year Performance	-74.80%	-8.97%	159.23%	27.13%

Veea Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VEEA Veea	0.9854 of 5 stars	$0.60 +0.6%	N/A	-75.8%	$29.91M	$220K	N/A	50	Positive News Earnings Report
PODC PodcastOne	1.4411 of 5 stars	$3.70 +1.4%	N/A	+82.7%	$101.74M	$52.12M	N/A	N/A
CANG Cango	2.8528 of 5 stars	$0.57 -2.5%	$3.00 +428.2%	-88.7%	$100.92M	$688.08M	N/A	2,350	Upcoming Earnings Analyst Upgrade Gap Down
HCAT Health Catalyst	2.2169 of 5 stars	$1.34 -9.8%	$2.77 +107.7%	-67.4%	$98.24M	$311.14M	N/A	1,200
DH Definitive Healthcare	3.3966 of 5 stars	$0.92 -0.5%	$2.77 +200.1%	-73.5%	$97.29M	$238.26M	N/A	970

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VEEA) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Veea (VEEA) Competitors